QUBT:NASDAQQuantum Computing Inc. Analysis
Data as of 2026-05-19 - not real-time
$9.72
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Quantum Computing Inc. is trading at $9.72, just below its 20‑day SMA of 9.76 and above the 50‑day SMA of 8.39, while the MACD line sits marginally above its signal (0.64 vs 0.62), indicating a subtle bullish tilt. Volume is on an increasing trend and the RSI of 51 suggests the stock is neither overbought nor oversold. Analyst consensus is optimistic, with a median price target of $18 and an implied upside of 83 %, reflected in the “Extreme Greed” reading of 89.68 on the fear‑greed index. However, the fundamentals tell a cautionary story: revenue surged 93 % YoY but margins remain deeply negative (gross margin -15 %, operating margin -5.6 %) and cash burn persists despite a strong cash pile of $986 M. The stock’s 30‑day volatility exceeds 100 % and beta is above 3.4, underscoring pronounced price swings. With a price‑to‑sales multiple of over 500× and a forward PE of -44.8, valuation is stretched relative to earnings. The company’s cash‑rich balance sheet and unique photonic quantum‑computing platform provide a speculative upside, but the combination of high volatility, negative earnings, and a massive drawdown history (-74 %) amplifies risk. In short, the market is pricing a high‑growth narrative on a financially fragile foundation, making the stock a high‑risk, high‑reward play.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with rising volume
- Analyst upside potential of >80 %
- Price near short‑term support at $7.98
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Rapid revenue growth (~93 %) despite early‑stage margins
- Strong cash position ($986 M) relative to minimal debt
- Strategic positioning in quantum photonics for government and commercial markets
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Persistent negative profitability and high cash burn
- Extreme price volatility and beta indicating market sensitivity
- Uncertain timeline for commercial quantum‑computing adoption
Key Metrics & Analysis
Financial Health
Revenue Growth9364.10%
P/E Ratio-44.8
ROE-4.37%
ROA-4.25%
Debt/Equity0.34
P/B Ratio1.4
Op. Cash Flow$-35286000
Free Cash Flow$-40361376
Industry P/E38.2
Technical Analysis
TrendNeutral
RSI51.1
Support$7.98
Resistance$14.45
MA 20$9.76
MA 50$8.39
MA 200$12.33
MACDBullish
VolumeIncreasing
Fear & Greed Index89.68
Valuation
Target Price$17.83
Upside/Downside83.56%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.46
Volatility104.58%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.